BAY 41-8543
CAS No. 256498-66-5
BAY 41-8543( BAY 418543 )
Catalog No. M13773 CAS No. 256498-66-5
BAY 41-8543 is an NO-independent sGC (soluble guanylyl cyclase) stimulator, inhibits collagen-mediated aggregation in washed human platelets (IC50=90 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 60 | Get Quote |
|
| 5MG | 84 | Get Quote |
|
| 10MG | 149 | Get Quote |
|
| 25MG | 309 | Get Quote |
|
| 50MG | 514 | Get Quote |
|
| 100MG | 737 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBAY 41-8543
-
NoteResearch use only, not for human use.
-
Brief DescriptionBAY 41-8543 is an NO-independent sGC (soluble guanylyl cyclase) stimulator, inhibits collagen-mediated aggregation in washed human platelets (IC50=90 nM).
-
DescriptionBAY 41-8543 is an NO-independent sGC (soluble guanylyl cyclase) stimulator, inhibits collagen-mediated aggregation in washed human platelets (IC50=90 nM); BAY 418543 is a potent direct stimulator of the cyclic GMP/PKG/VASP pathway in platelets and synergizes with NO over a wide range of concentrations. Hypertension Discontinued.
-
In Vitro——
-
In VivoBAY 41-8543 (10-100 μg/kg; IV) produces small decreases in pulmonary arterial pressure, larger dose-dependent decreases in systemic arterial pressure, and increases in cardiac output.BAY 41-8543 (0.003, 0.01, 0.03, 0.1, and 0.3?mg/kg; iv) produces a dose-dependent and long-lasting decrease in blood pressure in anaesthetized rats. The blood pressure lowering effect of BAY 41-8543 lasts longer than the observation period of 30?min. BAY 41-8543 (0.1, 0.3 and 1.0?mg?kg; oral) has maximal blood pressure lowering effects. The blood pressure lowering effects of the highest doses of BAY41-8543 lasts longer than the observation period of 120?min. BAY 41-8543 (3?mg/kg; p.o.; twice daily; for 5 weeks) completely prevents the development of the increase in systolic blood pressure in 18-week-old renin transgenic rats (TGR(mRen2)27) on L-NAME treatment. BAY 41-8543 dramatically increases survival. Animal Model:Adult male Sprague-Dawley rats weighing 325-450 g Dosage:10, 30, and 100 μg/kg Administration:IV Result:Produced small decreases in pulmonary arterial pressure, larger dose-dependent decreases in systemic arterial pressure, and increases in cardiac output.
-
SynonymsBAY 418543
-
PathwayMetabolic Enzyme/Protease
-
TargetGuanylate Cyclase
-
RecptorGuanylate Cyclase
-
Research AreaCardiovascular Disease
-
IndicationHypertension
Chemical Information
-
CAS Number256498-66-5
-
Formula Weight420.452
-
Molecular FormulaC21H21FN8O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMF : 16.67 mg/mL (39.65 mM)
-
SMILESc1ccc(c(c1)Cn2c3c(cccn3)c(n2)c4nc(c(c(n4)N)N5CCOCC5)N)F
-
Chemical Name2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-(4-morpholinyl)-4,6-pyrimidinediamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Stasch JP, et al. Br J Pharmacol. 2002 Jan;135(2):333-43.
2. Stasch JP, et al. Br J Pharmacol. 2002 Jan;135(2):344-55.
3. Amirjanians M, et al. Oncotarget. 2017 May 2;8(18):29613-29624.
molnova catalog
related products
-
Nelociguat
Nelociguat(BAY60-4552) is a soluble guanylate cyclase stimulator (sGC stimulator). Soluble guanylate cyclase (sGC) is a key enzyme in the nitric oxide (NO) signalling pathway.
-
Indusatumab
Indusatumab (5F9 Monoclonal antibody) is an anti-human GUCY2C (Guanylate cyclase 2C) monoclonal antibody utilized for synthesizing antibody-drug conjugates.
-
Sinitrodil
Sinitrodil (ITF-296) is a guanylate cyclase stimulant that may be used in the treatment of myocardial ischemia and angina pectoris.
Cart
sales@molnova.com